Announcements Trials

Browse Landscape

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 55 Endometrial Neoplasms 4 Polycystic Ovary Syndrome 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Recurrence 2 Neoplasms 2 Infertility 2 Carcinoma, Ductal, Breast 2 Breast Neoplasm Female 2 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 Neoplasms by Site 1 Liposarcoma 1 Inflammatory Breast Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Cystadenocarcinoma, Serous 1 Colorectal Neoplasms 1 Carcinoma, Lobular 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1 Breast Diseases 1 Breast Cancer Female 1 Anovulation 1 Advanced Breast Carcinoma 1 Adenocarcinoma of Lung 1

Interventions

Tamoxifen 2 pyrotinib 1 exemestane 1 abemaciclib 1 Surgical Procedures, Operative 1 Radiotherapy 1 Radiation Dose Hypofractionation 1 Mammaplasty 1 Letrozole 1 Drug Therapy 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Breast Cancer Female × Letrozole × Clear all

NCT04584853 2026-01-14

POETIC-A

Institute of Cancer Research, United Kingdom

Phase 3 Active not recruiting

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡